How can a single enantiomer provide superior efficacy to the chiral mixture?

On a theoretical basis, a single enantiomer might provide superior therapy because it:

• reduces the dose given, and thereby reduces the metabolic load
• reduces interpatient variability in metabolism/response
• simplifies dose–response relationships
• removes an inactive/undesirable ‘impurity’